Can FDA Approval Bolster DexCom, Inc.?

10:33am, Wednesday, 14'th Dec 2022
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value).
One of our favorite CGM systems is getting an upgrade. The G7 is smaller than the G6, takes less time to warm up and comes with an improved app and alerts.
Dexcom stock jumped Thursday after the FDA cleared its next-generation continuous glucose monitor for patients with diabetes. The post Dexcom Flirts With Breakout After FDA Clears Next-Gen Diabetes De

3 Supercharged Growth Stocks to Buy for 2023

05:23am, Thursday, 01'st Dec 2022
Next year could be a very important one for all three of these fast-growing businesses.
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.

Is This Stock-Split Stock a Buy For 2023?

10:00am, Saturday, 26'th Nov 2022
Don't buy this company's shares for its recent stock split.

Dexcom Leads 5 Stocks Near Buy Points

07:45am, Friday, 25'th Nov 2022
Dexcom and other top stocks to watch this week combine strong technicals with generally solid fundamentals. The post Dexcom Leads 5 Stocks Near Buy Points appeared first on Investor's Business Daily.
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up B
Don't let the current market keep you from putting spare cash to work in great companies.
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
When searching for growth stocks to buy, investors should first ascertain what growth means to them. It varies from person to person.
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead.
These widely held stock-split stocks put the bear market in its place by respectively gaining 27% and 50% in October.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE